Page last updated: 2024-10-29

imipramine and Carcinoma, Transitional Cell

imipramine has been researched along with Carcinoma, Transitional Cell in 1 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Turner, RM1
Love, CC1
McDonnell, SM1
Sweeney, RW1
Twitchell, ED1
Habecker, PL1
Reilly, LK1
Pozor, MA1
Kenney, RM1

Other Studies

1 other study available for imipramine and Carcinoma, Transitional Cell

ArticleYear
Use of imipramine hydrochloride for treatment of urospermia in a stallion with a dysfunctional bladder.
    Journal of the American Veterinary Medical Association, 1995, Dec-15, Volume: 207, Issue:12

    Topics: Abdominal Neoplasms; Adrenergic Uptake Inhibitors; Animals; Carcinoma, Transitional Cell; Female; Ho

1995